Abstract
A single-dose study was conducted to determine concentrations of trovafloxacin (CP-99,219) achieved in the cerebrospinal fluid (CSF) relative to those in the serum of healthy subjects after intravenous infusion of alatrofloxacin (CP-116,517), the alanyl-alanyl prodrug of trovafloxacin. Twelve healthy subjects were administered single doses of alatrofloxacin at a trovafloxacin equivalent of 300 mg as an intravenous infusion over 1.0 h. CSF samples were taken by lumbar puncture at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 24 h after the start of the infusion; each subject was sampled at only one time point. Serum samples were taken from each subject at the time of CSF collection. A mean concentration of 5.8 microg of trovafloxacin per ml was present in serum 1.0 h after the start of the infusion. CSF/serum ratios ranged from 0.14 to 0.33 in the postdistribution phase (5 to 24 h postinfusion), with a mean ratio of 0.25. The most common adverse events were dizziness, nausea, and rash and were mild or moderate in intensity. The potency of trovafloxacin against susceptible organisms, coupled with its rapid penetration of CSF following the intravenous administration of alatrofloxacin, suggests that it may be useful in the treatment of ba...Continue Reading
References
Dec 1, 1991·Mayo Clinic Proceedings·R C Walker, A J Wright
Dec 30, 1991·The American Journal of Medicine·J S Wolfson, D C Hooper
Apr 1, 1991·The Journal of Clinical Endocrinology and Metabolism·J BruceE Oldfield
Dec 1, 1988·Neurosurgery·J N Bruce, E H Oldfield
Jun 1, 1994·Drugs·N von Rosenstiel, D Adam
Jun 1, 1995·Antimicrobial Agents and Chemotherapy·M M ParísG H McCracken
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·R NauM G Täuber
Oct 1, 1994·Antimicrobial Agents and Chemotherapy·S K SpanglerP C Appelbaum
Feb 1, 1993·Antimicrobial Agents and Chemotherapy·B B Gooding, R N Jones
Feb 1, 1993·Antimicrobial Agents and Chemotherapy·G M EliopoulosR C Moellering
Aug 1, 1995·The Journal of Antimicrobial Chemotherapy·R TengT E Liston
Jan 12, 1996·Journal of Chromatography. B, Biomedical Applications·R TengG Foulds
May 1, 1996·The Journal of Antimicrobial Chemotherapy·R TengS C Harris
Citations
Jan 23, 1999·Pharmacotherapy·K W Garey, G W Amsden
May 1, 2001·The Journal of Antimicrobial Chemotherapy·C J DestacheA K Dash
Jan 16, 2002·Drugs·George G ZhanelDaryl J Hoban
Oct 20, 2001·Pharmacotherapy·D N Fish
Sep 29, 2006·The Pediatric Infectious Disease Journal·Monique A J M Trijbels-SmeuldersMieke A A Hoogkamp-Korstanje
Dec 13, 2006·Treatments in Respiratory Medicine·George G ZhanelDaryl J Hoban
Feb 11, 1999·The Annals of Pharmacotherapy·A A Alghasham, M C Nahata
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·D RodoniP Cottagnoud
Oct 3, 1999·Antimicrobial Agents and Chemotherapy·F FitoussiE Bingen
Jul 2, 1999·Antimicrobial Agents and Chemotherapy·C MicheletM G Täuber
Apr 29, 1998·Antimicrobial Agents and Chemotherapy·D P NicolauC H Nightingale
Apr 15, 2000·Diagnostic Microbiology and Infectious Disease·P R TessierD P Nicolau